Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

AVEO Pharmaceuticals Inc (AVEO) Stock Forecast 2025 - AI Price Prediction & Analysis

AVEO Pharmaceuticals Inc (AVEO) AI Stock Price Forecast & Investment Analysis

AVEO Pharmaceuticals Inc Stock Price Chart and Technical Analysis

Loading AVEO Pharmaceuticals Inc interactive price chart and technical analysis...

AVEO Pharmaceuticals Inc (AVEO) - Comprehensive Stock Analysis & Investment Research

Deep dive into AVEO Pharmaceuticals Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about AVEO Pharmaceuticals Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For AVEO Pharmaceuticals Inc: AVEO Pharmaceuticals Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

AVEO Pharmaceuticals Inc (Stock Symbol: AVEO) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 115 professionals worldwide and operates under the strategic leadership of CEO Michael Bailey.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing AVEO Pharmaceuticals Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AVEO Pharmaceuticals Inc: With $8M in annual revenue and -242.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $8 million generating a -242.6% net profit margin .

Market Capitalization: $519 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -75.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for AVEO Pharmaceuticals Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For AVEO Pharmaceuticals Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for AVEO Pharmaceuticals Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: AVEO Pharmaceuticals Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For AVEO Pharmaceuticals Inc: Market positioning analysis based on available financial and operational metrics.

AVEO Pharmaceuticals Inc strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 802.9% gross margin, indicating strong pricing power and operational efficiency.

AVEO Pharmaceuticals Inc (AVEO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for AVEO Pharmaceuticals Inc stock analysis.

Loading AVEO Pharmaceuticals Inc comprehensive fundamental analysis and insider trading data...

Deep dive into AVEO Pharmaceuticals Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if AVEO Pharmaceuticals Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For AVEO Pharmaceuticals Inc: With a P/E ratio of -15.51, the market sees the stock as potentially undervalued.

P/E Ratio -15.51x
P/B Ratio 18.00x
Market Cap $519M
EPS $-0.63
Book Value/Share $0.83
Revenue/Share $2.72
FCF/Share $-1.73
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently AVEO Pharmaceuticals Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AVEO Pharmaceuticals Inc: An ROE of -75.7% indicates room for improvement in shareholder value creation.

ROE -75.7%
ROA -36.7%
ROIC -40.8%
Gross Margin 802.9%
Operating Margin -284.5%
Net Margin -242.6%
EBT Margin -67.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess AVEO Pharmaceuticals Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For AVEO Pharmaceuticals Inc: A current ratio of 4.81 indicates strong liquidity.

Current Ratio 4.81x
Quick Ratio 4.57x
D/E Ratio 1.03x
Financial Leverage 2.66x
Interest Coverage -8.0x
Working Capital $49M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal AVEO Pharmaceuticals Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For AVEO Pharmaceuticals Inc: Free cash flow of $-47M indicates cash challenges that need attention.

Operating Cash Flow $-47M
Free Cash Flow $-47M
FCF/Sales -76.9%
CapEx/Sales 6.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively AVEO Pharmaceuticals Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For AVEO Pharmaceuticals Inc: An asset turnover of 0.54x suggests room for improvement in asset utilization.

Asset Turnover 0.54x
Receivables Turnover 8.7x
Inventory Turnover 4.2x
Fixed Assets Turnover 81.5x
Days Sales Outstanding 42 days
Days Inventory 88 days
Payables Period 181 days
Cash Conversion Cycle -51 days
Understanding Financial Statement Data

What these metrics mean: Key figures from AVEO Pharmaceuticals Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For AVEO Pharmaceuticals Inc: With annual revenue of $8M, AVEO Pharmaceuticals Inc represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $8M
Operating Income $-24M
Net Income $-20M
R&D Expense $40M
SG&A Expense $103M
Cost of Goods Sold $9M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 100%
Cash & Short-term Investments 80%
Total Liabilities 62%
Short-term Debt 2%
Accounts Receivable 14%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 35M
Growth Metrics (YoY)
EPS Growth -4.2%

Latest AVEO Pharmaceuticals Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting AVEO Pharmaceuticals Inc (AVEO) stock price and investment outlook.

, source: Reuters

BOSTON, March 24 (Reuters) - Biogen Idec Inc has acquired an option to license the rights to certain experimental cancer drugs being developed by privately held Aveo Pharmaceuticals Inc. Sign up here.

, source: Seeking Alpha

– Total Q3 2022 Net Revenue of $30.4 million, including $30.2 million of FOTIVDA® (tivozanib) U.S. Net Product Revenue – – Announced entering a definitive agreement under which LG Chem will acquire ...

AVEO Pharmaceuticals Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of AVEO Pharmaceuticals Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - AVEO Pharmaceuticals Inc Stock Forecast

How accurate are AVEO Pharmaceuticals Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for AVEO predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence AVEO Pharmaceuticals Inc stock price forecasts?

Our analysis considers AVEO Pharmaceuticals Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is AVEO Pharmaceuticals Inc a good investment in 2025?

Based on our AI analysis, AVEO Pharmaceuticals Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are AVEO Pharmaceuticals Inc forecasts updated?

AVEO Pharmaceuticals Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced AVEO Pharmaceuticals Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for AVEO Pharmaceuticals Inc stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...